Pay in 4 interest-free payments of $6.11 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
In the only head-to-head trial, Wegovy achieved 15.8% weight loss compared with 6.4% for Saxenda over 68 weeks
Factors such as starting weight, adherence to medication, and lifestyle choices like diet and physical activity play critical roles in the outcome of the treatment
Real-world data tells you what happens with everyone else
Three screening questionnaires, the Patient Health Questionnaire-9 (PHQ-9) [24], Generalised Anxiety Disorder-7 (GAD-7) [25] assessment and Eating Disorder Examination Questionnaire (EDE-Q) [26] were used for symptoms of depression, anxiety and eating disorders respectively
People with obesity may have higher health costs for a variety of reasons
Timing considerations when switching medications If you are switching from semaglutide to tirzepatide or going the other direction , timing the transition correctly matters
US$ 23.29
US$ 29.63
US$ 26.91
US$ 24.16
